Top Markets
Coin of the day
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFI
Classificação em ações #40134
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge,... Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.
Preço da ação
$0.0039
Última sincronização: 2023-10-27
Valor de mercado
$235.97K
Variação (1 dia)
-13.33%
Variação (1 ano)
0.00%
País
US
Negociar Infinity Pharmaceuticals, Inc. (INFI)

Categoria

Histórico de desdobramentos de ações de Infinity Pharmaceuticals, Inc. (INFI)
As ações Infinity Pharmaceuticals, Inc. (símbolo: INFI) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 14, 2026.
Uma ação INFI comprada antes de Aug 14, 2026 equivaleria hoje a 0 ações INFI.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE